176 related articles for article (PubMed ID: 9374380)
1. Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
Asakura T; Ohkawa K; Takahashi N; Takada K; Inoue T; Yokoyama S
Br J Cancer; 1997; 76(10):1333-7. PubMed ID: 9374380
[TBL] [Abstract][Full Text] [Related]
2. Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells.
Asakura T; Takahashi N; Takada K; Inoue T; Ohkawa K
Anticancer Drugs; 1997 Feb; 8(2):199-203. PubMed ID: 9073316
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cytocidal activity and glutathione-S-transferase inhibition using doxorubicin coupled to stereoisomers of glutathione with different substrate specificity.
Hashizume Y; Asakura T; Oikawa T; Yamauchi T; Soda K; Ohkawa K
Anticancer Drugs; 2001 Jul; 12(6):549-54. PubMed ID: 11460002
[TBL] [Abstract][Full Text] [Related]
4. Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells.
Asakura T; Hashizume Y; Tashiro K; Searashi Y; Ohkawa K; Nishihira J; Sakai M; Shibasaki T
Int J Cancer; 2001 Oct; 94(2):171-7. PubMed ID: 11668494
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate.
Tashiro K; Asakura T; Fujiwara C; Ohkawa K; Ishibashi Y
Anticancer Drugs; 2001 Sep; 12(8):707-12. PubMed ID: 11604559
[TBL] [Abstract][Full Text] [Related]
6. Bovine serum albumin-doxorubicin conjugate overcomes multidrug resistance in a rat hepatoma.
Ohkawa K; Hatano T; Yamada K; Joh K; Takada K; Tsukada Y; Matsuda M
Cancer Res; 1993 Sep; 53(18):4238-42. PubMed ID: 8364920
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.
Ohkawa K; Hatano T; Tsukada Y; Matsuda M
Br J Cancer; 1993 Feb; 67(2):274-8. PubMed ID: 8431358
[TBL] [Abstract][Full Text] [Related]
8. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
Asakura T; Sawai T; Hashidume Y; Ohkawa Y; Yokoyama S; Ohkawa K
Br J Cancer; 1999 May; 80(5-6):711-5. PubMed ID: 10360648
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic analysis of protein-conjugated doxorubicin (DXR) and its degraded adducts in DXR-sensitive and -resistant rat hepatoma cells.
Takahashi N; Asakura T; Ohkawa K
Anticancer Drugs; 1996 Aug; 7(6):687-96. PubMed ID: 8913438
[TBL] [Abstract][Full Text] [Related]
10. [Intracellular distribution of bovine serum albumin-conjugated doxorubicin and multidrug resistance].
Takahashi N; Asakura T; Ohkawa K; Fukuda K; Aoki T
Gan To Kagaku Ryoho; 1997 Jan; 24(1):87-92. PubMed ID: 9020950
[TBL] [Abstract][Full Text] [Related]
11. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
Gaudiano G; Koch TH; Lo Bello M; Nuccetelli M; Ravagnan G; Serafino A; Sinibaldi-Vallebona P
Biochem Pharmacol; 2000 Dec; 60(12):1915-23. PubMed ID: 11108808
[TBL] [Abstract][Full Text] [Related]
12. Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis.
Asakura T; Sasagawa A; Takeuchi H; Shibata S; Marushima H; Mamori S; Ohkawa K
Apoptosis; 2007 Jul; 12(7):1269-80. PubMed ID: 17431793
[TBL] [Abstract][Full Text] [Related]
13. Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture.
Benchekroun MN; Catroux P; Montaudon D; Robert J
Free Radic Res Commun; 1990; 11(1-3):137-44. PubMed ID: 1963616
[TBL] [Abstract][Full Text] [Related]
14. Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance.
Drozd E; Gruber B; Marczewska J; Drozd J; Anuszewska E
Postepy Hig Med Dosw (Online); 2016 Apr; 70():319-28. PubMed ID: 27117108
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
[TBL] [Abstract][Full Text] [Related]
16. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells.
Osmak M; Brozović A; Ambriović-Ristov A; Hadzija M; Pivcević B; Smital T
Neoplasma; 1998; 45(4):223-30. PubMed ID: 9890665
[TBL] [Abstract][Full Text] [Related]
18. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms.
Zhang K; Chew M; Yang EB; Wong KP; Mack P
Mol Pharmacol; 2001 Apr; 59(4):837-43. PubMed ID: 11259628
[TBL] [Abstract][Full Text] [Related]
20. Glutathione depletion in human and in rat multi-drug resistant breast cancer cell lines.
Batist G; Schecter R; Woo A; Greene D; Lehnert S
Biochem Pharmacol; 1991 Feb; 41(4):631-5. PubMed ID: 1997009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
